A comprehensive review of mRNA vaccines

V Gote, PK Bolla, N Kommineni, A Butreddy… - International journal of …, 2023‏ - mdpi.com
mRNA vaccines have been demonstrated as a powerful alternative to traditional
conventional vaccines because of their high potency, safety and efficacy, capacity for rapid …

mRNA vaccines for infectious diseases: principles, delivery and clinical translation

N Chaudhary, D Weissman… - Nature reviews Drug …, 2021‏ - nature.com
Over the past several decades, messenger RNA (mRNA) vaccines have progressed from a
scepticism-inducing idea to clinical reality. In 2020, the COVID-19 pandemic catalysed the …

[HTML][HTML] Pneumococcal vaccine for adults aged≥ 19 years: recommendations of the Advisory Committee on Immunization Practices, United States, 2023

M Kobayashi - MMWR. Recommendations and reports, 2023‏ - cdc.gov
This report compiles and summarizes all published recommendations from CDC's Advisory
Committee on Immunization Practices (ACIP) for use of pneumococcal vaccines in adults …

Surveillance for adverse events after COVID-19 mRNA vaccination

NP Klein, N Lewis, K Goddard, B Fireman, O Zerbo… - Jama, 2021‏ - jamanetwork.com
Importance Safety surveillance of vaccines against COVID-19 is critical to ensure safety,
maintain trust, and inform policy. Objectives To monitor 23 serious outcomes weekly, using …

[HTML][HTML] First month of COVID-19 vaccine safety monitoring—United States, December 14, 2020–January 13, 2021

J Gee - MMWR. Morbidity and mortality weekly report, 2021‏ - cdc.gov
First Month of COVID-19 Vaccine Safety Monitoring — United States, December 14, 2020–January
13, 2021 | MMWR Skip directly to site content Skip directly to search Español | Other …

mRNA vaccines to prevent COVID-19 disease and reported allergic reactions: current evidence and suggested approach

A Banerji, PG Wickner, R Saff, CA Stone Jr… - The Journal of Allergy …, 2021‏ - Elsevier
The US Food and Drug Administration (FDA) has recently issued an Emergency Use
Authorization (EUA) for 2 highly effective coronavirus disease 2019 (COVID-19) vaccines …

[HTML][HTML] Side effects of BNT162b2 mRNA COVID-19 vaccine: A randomized, cross-sectional study with detailed self-reported symptoms from healthcare workers

RAK Kadali, R Janagama, S Peruru… - International Journal of …, 2021‏ - Elsevier
Introduction Concerns are prevailing about the safety and side effects of the BNT162b2
mRNA vaccine for coronavirus disease 2019 (COVID-19). Methods A randomized, cross …

Biological and clinical aspects of HPV-related cancers

KA Szymonowicz, J Chen - Cancer biology & medicine, 2020‏ - cancerbiomed.org
Cancer-related diseases represent the second overall cause of death worldwide. Human
papilloma virus (HPV) is an infectious agent which is mainly sexually transmitted and may …

[HTML][HTML] Recent advancement in mRNA vaccine development and applications

N Al Fayez, MS Nassar, AA Alshehri, MK Alnefaie… - Pharmaceutics, 2023‏ - mdpi.com
Messenger RNA (mRNA) vaccine development for preventive and therapeutic applications
has evolved rapidly over the last decade. The mRVNA vaccine has proven therapeutic …

[HTML][HTML] Prevention of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices

S Schillie - MMWR. Recommendations and reports, 2018‏ - cdc.gov
Hepatitis B virus (HBV) is transmitted via blood or sexual contact. Persons with chronic HBV
infection are at increased risk for cirrhosis and liver cancer and require medical care. This …